Related Experiment Videos

The sequelae of group B beta-hemolytic streptococcal meningitis in early infancy

Insights

Group B beta-hemolytic streptococcus causes increasing neonatal meningitis. While mortality was 17%, outcomes were better than other bacterial meningitis types, with few major long-term issues in survivors.

Area of Science:

  • Neonatal infections
  • Bacterial meningitis
  • Pediatric neurology

Background:

  • Group B beta-hemolytic streptococcus (GBS) is an increasing cause of neonatal meningitis.
  • Neonatal meningitis poses significant risks for mortality and long-term neurological impairment.

Purpose of the Study:

  • To assess the mortality and morbidity associated with GBS meningitis in neonates.
  • To compare the outcomes of GBS meningitis with other forms of neonatal bacterial meningitis.

Main Methods:

  • Retrospective analysis of 18 consecutive cases of neonatal meningitis caused by GBS.
  • Evaluation of mortality rates and neurological/psychological outcomes in survivors.
  • Comparison of survivors with control groups on various functional assessments.

Main Results:

  • The study reported a 17% mortality rate among the 18 cases of GBS meningitis.
  • Two of the 15 survivors experienced extensive neurological and psychological impairment.
  • No significant differences were found in hearing, language, social skills, or psychological testing between survivors and controls, though minor neurological signs were more common in the GBS group.

Conclusions:

  • Neonatal meningitis due to GBS has a lower mortality and morbidity rate compared to other bacterial meningitis types.
  • While severe impairment occurred in some survivors, overall outcomes suggest a comparatively better prognosis for GBS meningitis.
  • Continued surveillance and understanding of GBS meningitis are crucial for neonatal care.

Related Concept Videos